MEA Digital Therapeutics Market

MEA Digital Therapeutics Market Size (2023 to 2028)

The size of the Middle East and Africa digital therapeutics market is estimated to grow healthy during the forecast period.

The rising prevalence of chronic diseases in the Middle East and Africa region is one of the key factors propelling the digital therapeutics market in this region. Advanced digital therapeutic products are being introduced to the market, such as wearable devices that capture patient symptoms and monitor treatment efficacy. These products are particularly useful in cardiovascular therapy, where they help guide medication and monitor patient behavior to optimize treatment outcomes. Additionally, digital therapeutics can be used to predict chronic diseases and identify other healthcare conditions among the population. They are also effective in treating neurological disorders and can aid in reducing or preventing addiction to harmful substances such as drugs, alcohol, and tobacco. The potential applications of digital therapeutics are vast and varied and their use is expected to continue growing in the MEA region.

The growing adoption of technological advancements in digital therapeutics is contributing to the growth of the MEA digital therapeutics market. Healthcare providers and researchers have been working together to develop digital therapeutics for oncology, cardiovascular diseases and others. Manufacturers also focus on developing digital therapeutics with advanced features like big data and artificial intelligence to ensure the best possible design, clinical support and data security. Furthermore, they manufacture medical products used in digital therapeutics to monitor and track patients' health throughout treatment. The wide range of applications for digital therapeutics, including promoting adherence to prescribed treatments, diets, and exercise regimens, also contribute to the market's growth. With the ongoing development of cutting-edge technologies and increasing patient demand, the market for digital therapeutics is poised for continued growth.

Factors such as rising awareness about digital therapeutics and the growing geriatric population support the digital therapeutics market in MEA. To promote the benefits of digital therapeutics among the population, the government has launched awareness campaigns. Digital therapeutics is a component of digital health that delivers evidence-based therapeutic interventions directly to the patient through clinical evaluation software. The development of medical devices for monitoring and tracking patients' health during treatment, rising applications of digital therapeutics for delivering therapy, tracking progress, and encouraging patient compliance and growing awareness about digital therapeutics among patients and healthcare providers further propel the growth of the digital therapeutics market in MEA.

On the other hand, factors such as limited access to healthcare infrastructure in certain areas, lack of trained healthcare professionals to handle digital therapeutics, regulatory challenges in digital health, high cost associated with digital therapeutics and lack of reimbursement policies for digital therapeutics hamper the growth of the digital therapeutics market in the Middle East and Africa.

The research report on MEA digital therapeutics market has been segmented and sub-segmented into the following categories.

By Product:

• Software
• Device
• Others

By Sales Channel:

• B2C
  • Patients
  • Caregivers
• B2B
  • Providers
  • Payers
  • Employers
  • Pharmaceutical Companies
  • Other Buyers

By Application:

• Preventive Applications
  • Prediabetes
  • Obesity
  • Nutrition
  • Lifestyle Management
  • Other Preventive Applications
• Treatment/Care-related Applications
  • Diabetes
  • CNS Disorders
  • Chronic Respiratory Disorders
  • Musculoskeletal Disorders
  • Cardiovascular Diseases
  • Smoking Cessation
  • Medication Adherence
  • Gastrointestinal Disorders
  • Substance Use & Addiction Management
  • Rehabilitation & Patient Care
  • Other Treatment/Care-related Applications

By Country:

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

The Middle East and Africa accounted for a moderate share of the worldwide market in 2022. However, the regional market is anticipated to register a healthy CAGR during the forecast period due to the increasing focus of international market participants to capture the potential of the MEA region, increasing improvements in the healthcare infrastructure, rising number of initiatives by the governments of MEA countries in favor of digital healthcare and the growing prevalence of chronic diseases. Among the MEA countries, the UAE is anticipated to hold a notable share of the MEA market during the forecast period. This is attributed to a large and relatively younger population that presents a substantial target base, as well as rapid urbanization and digitization. Additionally, ongoing reforms to address inadequate infrastructure and ensure sustainable growth through financial inclusion are expected to impact the market positively.

The Saudi Arabian market is projected to register a healthy CAGR during the forecast period owing to the increasing number of internet users accessing the internet through mobile devices, falling smartphone prices, enhanced accessibility of mobile data, an increasing number of rural users and various government initiatives. Other countries such as Kuwait, Qatar, and Oman are also expected to exhibit a healthy growth rate, while the African continent regions will experience a slower growth rate.

KEY MARKET PLAYERS:

2Morrow, Inc., Pear Therapeutics, Inc., Fitbit, Inc. (Twine Health, Inc.), Proteus Digital Health, Inc., Livongo Health, Inc., Resmed, Inc. (Propeller Health), Voluntis, Inc., Omada Health, Inc., Welldoc, Inc., and Medtronic Plc are some of the notable players in the MEA digital therapeutics market.